News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Coen Stacy Ann
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Sold 100,210 shares
@ $14.2, valued at
$1.4M
Exercised 100,210 options to buy
@ $4.92, valued at
$493k
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
4
| Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Sold 4,255 shares
@ $18.12, valued at
$77.1k
Sold 80,326 shares
@ $17.05, valued at
$1.4M
Exercised 4,255 options to buy
@ $4.92, valued at
$20.9k
Exercised 80,326 options to buy
@ $4.92, valued at
$395.2k
|
|
| 08/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,792 shares
@ $4.05, valued at
$15.4k
|
|
| 02/07/2023 |
4
| Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 41,000 restricted stock units
@ $0
Granted 245,900 options to buy
@ $4.66, valued at
$1.1M
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Coen Stacy Ann (SVP & Chief Business Officer) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 1,496 shares
@ $5.6, valued at
$8.4k
|
|
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| Coen Stacy Ann (Chief Business Officer) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 260,000 options to buy
@ $4.92, valued at
$1.3M
|
|
| 06/04/2020 |
3
| Coen Stacy Ann (Chief Business Officer) has filed a Form 3 on ImmunoGen, Inc. |
|
|